DLA Piper announced Monday that George Karavetsos, who until Friday was the director of the U.S. Food and Drug Administration’s Office of Criminal Investigations, has joined the firm’s litigation practice as a partner.
Karavetsos, who will work out of the firm’s Miami office, will focus on pharmaceutical, medical device, food, dietary supplement, tobacco and health care matters, advising the firm’s broad array of clients in these sectors, the firm said. Loren Brown, DLA Piper’s co-chairman of global and U.S. litigation, said in a statement that Karavetsos brings with him a “unique combination of white collar and FDA regulatory experience.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
